GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Medicis Pharmaceutical Corporation (MRX) [hlAlert]

Medicis Pharmaceutical Corporation (Medicis) is an independent specialty pharmaceutical company focused primarily on helping patients attain a healthy and youthful appearance and self-image through the development and marketing in the United States of products for the treatment of dermatological, aesthetic and podiatric
conditions. It also markets products in Canada for the treatment of dermatological and aesthetic conditions. It offers a range of products addressing various conditions or aesthetic improvements, including facial wrinkles, acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, skin and skin-structure infections, seborrheic dermatitis and cosmesis. It offers 18 branded products, including PERLANE (hyaluronic acid), RESTYLANE (hyaluronic acid), SOLODYN (minocycline HCl, USP), TRIAZ (benzoyl peroxide), VANOS (fluocinonide) Cream 0.1%, and ZIANA (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel. On July 1, 2008, the Company acquired LipoSonix, Inc.
.
( Total: 23 Current Stock Recommendations )
Medicis Pharmaceutical Corporation   (23)
Sell Hold 57% Buy 39%
Related companies
China Biologic ...   (4)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Talecris ...   (4)
Buy 100%
Anacor ...   (6)
Buy 100%
Santarus, Inc.   (13)
Hold 31% Buy 69%
Cardinal Health, ...   (24)
Hold 29% Buy 71%
Incyte Corporation   (22)
Sell Hold Buy 82%
Nbty, Inc.   (9)
Hold 44% Buy 56%
Dr. Reddy's ...   (5)
Sell 20% Hold 40% Buy 40%
Salix ...   (31)
Hold 39% Buy 61%
Filter by Gains:   
  
Rating:
Hold MRX

Rating:
Hold MRX
Medicis Pharmaceutical Corporation (MRX) rated Neutral by Goldman
Wednesday,  Sep 5, 2012  8:25 AM ET

Rating:
Hold MRX

Rating:
Buy MRX
up 14.02 %

Rating:
Buy MRX
up 26.41 %

Rating:
Buy MRX
up 19.28 %

Rating:
Hold MRX

Rating:
Hold MRX

Rating:
Hold MRX

Rating:
Buy MRX
up 26.41 %

Your Recent Stocks
SymbolLastChange
MRX 43.98 up  0.04 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy